The U.S. FDA Confirms Moderna Vaccine’s Efficacy Ahead of Thursday’s Meeting, World News

The USb FDA confirmed the safety and effectiveness of Moderna’s Covid vaccine ahead of a meeting on Thursday.

The FDA said the mRNA vaccine is 94.1% effective in preventing coronavirus, confirming previous results published by the company.

The report came two days before the Independent Advisory Committee on Vaccines and Related Biological Products meeting on Thursday to discuss safety and efficacy data and vote on recommending an emergency approval.

“The FDA believes that the totality of the data available is sufficient to support an evaluation of this product for the EEA,” said a 54-page information document from the Food and Drug Administration.

The most common side effects reported in the study participants were only injection site pain, fatigue, headache, muscle pain, joint pain, and chills.

The suggested use of the vaccine is for adults aged 18 and over.

The US approved the emergency use of the Pfizer coronavirus vaccine last week – just a day after the VRBPAC meeting under pressure from President Trump. The doses were then given on Monday.